PS Ratio: 5.18

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 5.18 is 59% above its estimated 5-year average of 3.26, around the middle of its estimated 5-year range (1.33–7.03).

As of 2026-10-06T21:43:33.282Z. 16.90% above its estimated 12-month average of 4.43.

XERS PS Ratio Metrics

P/S vs. estimated history

At 5.18, P/S is near its estimated 8-year median — higher than 58% of readings in its estimated 8-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Xeris Biopharma Holdings, Inc. (XERS)?

The P/S ratio for XERS stock is 5.18.

Is Xeris Biopharma Holdings, Inc.'s P/S ratio high or low?

The P/S ratio of 5.18 is 59% above its estimated 5-year average of 3.26, around the middle of its estimated 5-year range (1.33–7.03).

What is the estimated TTM average P/S ratio for Xeris Biopharma Holdings, Inc. (XERS)?

The estimated TTM average P/S ratio for XERS stock is 4.43.

What is the estimated 3Y average P/S ratio for Xeris Biopharma Holdings, Inc. (XERS)?

The estimated 3Y average P/S ratio for XERS stock is 3.25.

What is the estimated 5Y average P/S ratio for Xeris Biopharma Holdings, Inc. (XERS)?

The estimated 5Y average P/S ratio for XERS stock is 3.26.

Showing the most recent 260 of 2,083 data points. The chart above shows the full history.

Related Metrics